Last updated January 10, 2022

Early Detection of Prostate Cancer

Guideline Statements

The Panel recommends against PSA screening in men under age 40 years. (Moderate, C)
322859

The Panel does not recommend routine screening in men between ages 40 to 54 years at average risk. (Moderate, C)
322859

For men ages 55 to 69 years the Panel recognizes that the decision to undergo PSA screening involves weighing the benefits of preventing prostate cancer mortality in 1 man for every 1,000 men screened over a decade against the known potential harms associated with screening and treatment. For this reason, the Panel strongly recommends shared decision-making for men age 55 to 69 years that are considering PSA screening and proceeding based on a man's values and preferences. (Strong, B)
322859

To reduce the harms of screening, a routine screening interval of two years or more may be preferred over annual screening in those men who have participated in shared decision-making and decided on screening. As compared to annual screening, it is expected that screening intervals of two years preserve the majority of the benefits and reduce over diagnosis and false positives. (Conditional, C)
322859

The Panel does not recommend routine PSA screening in men age 70 years or more, or any man with less than a 10 to 15 year life expectancy. (Moderate, C)
322859

Recommendation Grading

Overview

Title

Early Detection of Prostate Cancer

Authoring Organization

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

The guideline purpose is to provide the urologist with a framework for the early detection of prostate cancer in asymptomatic average risk men.

Target Patient Population

Men at average risk for prostate cancer

Inclusion Criteria

Male, Adult

Health Care Settings

Ambulatory

Scope

Assessment and screening, Prevention

Diseases/Conditions (MeSH)

D017430 - Prostate-Specific Antigen, D055088 - Early Detection of Cancer

Keywords

prostatic neoplasms, early detection of cancer, prostatic cancer